USFDA gives nod for Docetaxel Injection USP

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Docetaxel Injection, of Hospira.

114
USFDA Drug product Approval
USFDA Approval

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Docetaxel Injection USP, 20 mg/2 mL (10 mg/mL) single-dose vial, and 80 mg/8 mL (10 mg/mL) and 160 mg/16 mL (10 mg/mL) multiple-dose vials.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Docetaxel Injection, 20 mg/2 mL, 80 mg/8 mL, and 160 mg/16 mL (10 mg/mL), of Hospira.

Docetaxcel Injections are indicated for breast cancer, non-small cell lung cancer, castration-resistant prostate cancer, gastric adenocarcinoma and squamous cell carcinoma of the head and neck.

Docetaxel Injection USP, 20 mg/2 mL (10 mg/mL) Single-Dose Vial, and 80 mg/8 mL (10 mg/mL) and 160 mg/16 mL (10 mg/mL) Multiple-Dose Vials, have an estimated market size of US$ 11 million for twelve months ending Dec 2022 according to IQVIA.

Alembic has a cumulative total of 181 ANDA approvals (158 final approvals and 23 tentative approvals) from USFDA.

USFDA gives nod for this generic medication for high BP

USFDA gives nod for this generic drug to lower cholesterol levels

USFDA approves bleeding disorder therapy

USFDA issues EIR to Strides for Bangalore facility

Hyderabad is having maximum USFDA approved Pharma Units in world

USFDA gives tentative nod for Gabapentin Tablets, 300 mg and 600 mg

Private hospital fined Rs 1 lakh for littering ‘Biomedical Waste’

Govt revises guidelines for PLI scheme for Medical Devices

Spurious drugs worth Rs 2 lakh seized, distributor arrested

NPPA revised Ceiling price of 80 scheduled formulations: February 2023

Worst medicine crisis in Pakistan

India aims to be the world’s most respected drugs regulator: HM

Duties and responsibilities of QA person in Pharma Industry

NPPA fixed retail price of 74 formulations: February 2023

Steep rise in prices of APIs hits Indian Pharma Companies

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news